Close

Ratings by BofA Securities (Tazeen Ahmad)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/17/2024 Sage Therapeutics SAGE Downgrade Underperform
(Neutral)
15.63
(13.37)
-14.46% Details
4/12/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
4/12/2024 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
4/12/2024 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
4/12/2024 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
4/12/2024 Ascendis Pharma ASND Maintain Buy
(N/A)
 
 
  Details
4/12/2024 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
4/12/2024 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
4/9/2024 Inozyme Pharma Inc. INZY Maintain Buy
(N/A)
 
 
  Details
3/13/2024 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
3/12/2024 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
2/28/2024 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
2/15/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
2/9/2024 Ocular Therapeutix OCUL New Coverage Buy
(N/A)
5.03
(6.25)
24.25% Details
1/30/2024 Prothena Corp PRTA Downgrade Neutral
(Buy)
33.76
(20.65)
-38.83% Details
1/22/2024 Ascendis Pharma ASND Maintain Buy
(N/A)
 
 
  Details
1/17/2024 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
1/12/2024 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
1/5/2024 Cyteir Therapeutics CYT Downgrade Underperform
(Neutral)
3.06
(3.02)
-1.31% Details
12/21/2023 Annexon Biosciences ANNX Upgrade Buy
(Neutral)
2.88
(4.60)
59.72% Details
12/14/2023 Achilles Therapeutics ACHL Downgrade Underperform
(Buy)
0.96
(0.80)
-16.67% Details
12/7/2023 Pharvaris B.V. PHVS Maintain Underperform
(N/A)
 
 
  Details
12/5/2023 Apellis Pharmaceuticals APLS Upgrade Buy
(Neutral)
61.58
(47.66)
-22.6% Details
11/2/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
10/31/2023 Sarepta Therapeutics SRPT Maintain Neutral
(N/A)
 
 
  Details
10/24/2023 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
10/17/2023 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
10/17/2023 PTC Therapeutics PTCT Maintain Underperform
(N/A)
 
 
  Details
10/17/2023 Incyte INCY Maintain Neutral
(N/A)
 
 
  Details
10/17/2023 Ascendis Pharma ASND Maintain Buy
(N/A)
 
 
  Details
10/17/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
10/17/2023 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
10/17/2023 ADC Therapeutics ADCT Maintain Underperform
(N/A)
 
 
  Details
10/17/2023 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
10/12/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
9/19/2023 PTC Therapeutics PTCT Maintain Underperform
(N/A)
 
 
  Details
9/8/2023 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
9/8/2023 Apellis Pharmaceuticals APLS Maintain Neutral
(N/A)
 
 
  Details
8/23/2023 Fulcrum Therapeutics FULC Maintain Underperform
(N/A)
 
 
  Details
8/7/2023 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
36.10
(13.37)
-62.96% Details
8/3/2023 Cerevel Therapeutics CERE Downgrade Neutral
(Buy)
26.33
(41.97)
59.4% Details
8/1/2023 Rhythm Pharmaceuticals RYTM Upgrade Buy
(Neutral)
17.84
(38.34)
114.91% Details
8/1/2023 Apellis Pharmaceuticals APLS Downgrade Neutral
(Buy)
0.00
(47.66)
0% Details
8/1/2023 Annexon Biosciences ANNX Maintain Neutral
(N/A)
 
 
  Details
7/18/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
6/23/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
6/8/2023 4D Molecular Therapeutics FDMT Maintain Buy
(N/A)
 
 
  Details
5/26/2023 Annexon Biosciences ANNX Downgrade Neutral
(Buy)
2.10
(4.60)
119.05% Details
5/22/2023 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
5/15/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/10/2023 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
5/10/2023 Ascendis Pharma ASND Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
5/5/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/4/2023 Incyte INCY Downgrade Neutral
(Buy)
68.04
(52.50)
-22.84% Details
5/3/2023 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
5/3/2023 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
4/24/2023 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
4/24/2023 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
4/24/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
4/24/2023 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
4/24/2023 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
4/24/2023 ADC Therapeutics ADCT Downgrade Underperform
(Neutral)
2.30
(4.85)
110.87% Details
3/28/2023 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
3/28/2023 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
3/14/2023 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
3/7/2023 Praxis Precision Medicines Inc. PRAX Maintain Neutral
(N/A)
 
 
  Details
3/7/2023 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
2/24/2023 Fulcrum Therapeutics FULC Downgrade Underperform
(Neutral)
12.89
(7.17)
-44.38% Details
2/21/2023 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
2/16/2023 Galera Therapeutics GRTX Upgrade Buy
(Underperform)
1.66
(0.19)
-88.55% Details
2/7/2023 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/30/2023 Cyteir Therapeutics CYT Downgrade Neutral
(Buy)
1.71
(3.02)
76.61% Details
1/10/2023 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
1/6/2023 Fate Therapeutics FATE Downgrade Underperform
(Buy)
11.00
(5.17)
-53% Details
1/4/2023 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/4/2023 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/16/2022 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
12/15/2022 BioNTech BNTX Upgrade Buy
(Neutral)
186.05
(86.00)
-53.78% Details
12/13/2022 4D Molecular Therapeutics FDMT Maintain Buy
(N/A)
 
 
  Details
12/9/2022 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
12/9/2022 Pharvaris B.V. PHVS Maintain Underperform
(N/A)
 
 
  Details
12/5/2022 Prothena Corp PRTA Maintain Buy
(N/A)
 
 
  Details
12/1/2022 SQZ Biotechnologies SQZ Downgrade Underperform
(Buy)
2.51
(0.44)
-82.47% Details
11/29/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
11/21/2022 Prelude Therapeutics PRLD Downgrade Underperform
(Neutral)
7.44
(4.02)
-45.97% Details
11/17/2022 Surrozen Inc. SRZN Downgrade Underperform
(Neutral)
1.25
(10.44)
735.2% Details
11/9/2022 ADC Therapeutics ADCT Downgrade Neutral
(Buy)
4.26
(4.85)
13.85% Details
11/8/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/4/2022 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
10/20/2022 Cerevel Therapeutics CERE New Coverage Buy
(N/A)
25.75
(41.97)
62.99% Details
9/28/2022 Prothena Corp PRTA Upgrade Buy
(Neutral)
30.93
(20.65)
-33.24% Details
8/24/2022 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
8/22/2022 Pharvaris B.V. PHVS Downgrade Underperform
(Neutral)
18.49
(20.29)
9.73% Details
8/18/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Praxis Precision Medicines Inc. PRAX Maintain Neutral
(N/A)
 
 
  Details
8/18/2022 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
8/18/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Rhythm Pharmaceuticals RYTM Upgrade Neutral
(Underperform)
18.59
(38.34)
106.24% Details
7/20/2022 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
6/15/2022 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
6/15/2022 Fulcrum Therapeutics FULC Maintain Neutral
(N/A)
 
 
  Details
6/8/2022 Annexon Biosciences ANNX Maintain Buy
(N/A)
 
 
  Details
6/7/2022 Praxis Precision Medicines Inc. PRAX Downgrade Neutral
(Buy)
1.88
(49.53)
2534.57% Details
5/31/2022 PepGen Inc. PEPG New Coverage Buy
(N/A)
10.88
(11.63)
6.89% Details
5/27/2022 Surrozen Inc. SRZN Downgrade Neutral
(Buy)
2.55
(10.44)
309.41% Details
5/27/2022 Molecular Templates MTEM Downgrade Underperform
(Buy)
0.97
(1.52)
56.7% Details
5/27/2022 Galera Therapeutics GRTX Downgrade Underperform
(Neutral)
1.74
(0.19)
-89.08% Details
5/24/2022 PTC Therapeutics PTCT Maintain Underperform
(N/A)
 
 
  Details
4/19/2022 Theravance Biopharma TBPH Maintain Underperform
(N/A)
 
 
  Details
4/19/2022 PTC Therapeutics PTCT Maintain Underperform
(N/A)
 
 
  Details
4/19/2022 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
4/19/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
4/19/2022 Ascendis Pharma ASND Maintain Neutral
(N/A)
 
 
  Details
4/19/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
4/19/2022 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
4/19/2022 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
4/19/2022 Ascendis Pharma ASND Maintain Buy
(N/A)
 
 
  Details
4/19/2022 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
4/8/2022 VectivBio Holding AG VECT Maintain Buy
(N/A)
 
 
  Details
3/31/2022 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
3/18/2022 SQZ Biotechnologies SQZ Maintain Buy
(N/A)
 
 
  Details
3/18/2022 Inozyme Pharma Inc. INZY Maintain Buy
(N/A)
 
 
  Details
3/15/2022 Ascendis Pharma ASND Upgrade Buy
(Neutral)
102.64
(142.85)
39.18% Details
3/15/2022 Prelude Therapeutics PRLD Downgrade Neutral
(Buy)
7.75
(4.02)
-48.13% Details
3/3/2022 Fulcrum Therapeutics FULC Upgrade Neutral
(Underperform)
11.10
(7.17)
-35.41% Details
3/3/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
3/3/2022 Ascendis Pharma ASND Maintain Neutral
(N/A)
 
 
  Details
3/1/2022 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
2/25/2022 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Rhythm Pharmaceuticals RYTM Maintain Underperform
(N/A)
 
 
  Details
2/9/2022 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
1/27/2022 Cortexyme Inc. CRTX Maintain Underperform
(N/A)
 
 
  Details
1/26/2022 Theravance Biopharma TBPH Maintain Underperform
(N/A)
 
 
  Details
1/26/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/26/2022 Rhythm Pharmaceuticals RYTM Maintain Underperform
(N/A)
 
 
  Details
1/26/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
1/26/2022 Prothena Corp PRTA Maintain Neutral
(N/A)
 
 
  Details
1/26/2022 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/26/2022 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
1/26/2022 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
1/26/2022 Clovis Oncology CLVS Maintain Underperform
(N/A)
 
 
  Details
1/26/2022 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
1/26/2022 Ascendis Pharma ASND Maintain Neutral
(N/A)
 
 
  Details
1/26/2022 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
1/13/2022 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/12/2022 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/21/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
12/14/2021 Galera Therapeutics GRTX Upgrade Neutral
(Underperform)
1.38
(0.19)
-86.23% Details
12/13/2021 Prelude Therapeutics PRLD Maintain Buy
(N/A)
 
 
  Details
12/6/2021 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
11/10/2021 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
11/2/2021 Pyxis Oncology Inc. PYXS New Coverage Neutral
(N/A)
13.20
(4.71)
-64.32% Details
10/29/2021 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
10/27/2021 Cortexyme Inc. CRTX Downgrade Underperform
(Neutral)
57.68
(1.95)
-96.62% Details
10/21/2021 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
10/21/2021 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
10/21/2021 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
10/21/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
10/20/2021 Ascendis Pharma ASND Downgrade Neutral
(Buy)
153.49
(142.85)
-6.93% Details
10/19/2021 Galera Therapeutics GRTX Downgrade Underperform
(Buy)
7.40
(1.38)
-81.35% Details
10/18/2021 PTC Therapeutics PTCT Downgrade Underperform
(Neutral)
38.09
(25.12)
-34.05% Details
10/11/2021 Surrozen Inc. SRZN New Coverage Buy
(N/A)
6.39
(10.44)
63.38% Details
9/24/2021 Fulcrum Therapeutics FULC Maintain Underperform
(N/A)
 
 
  Details
9/23/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
8/24/2021 Theravance Biopharma TBPH Maintain Underperform
(N/A)
 
 
  Details
8/11/2021 Fulcrum Therapeutics FULC Maintain Underperform
(N/A)
 
 
  Details
8/11/2021 Achilles Therapeutics ACHL Maintain Buy
(N/A)
 
 
  Details
8/5/2021 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/5/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
8/5/2021 SQZ Biotechnologies SQZ Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
8/4/2021 ADC Therapeutics ADCT Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Rhythm Pharmaceuticals RYTM Downgrade Underperform
(Neutral)
16.63
(38.34)
130.55% Details
8/4/2021 Pharvaris B.V. PHVS Maintain Neutral
(N/A)
 
 
  Details
8/3/2021 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
7/27/2021 Prelude Therapeutics PRLD Upgrade Buy
(Neutral)
33.33
(4.02)
-87.94% Details
7/21/2021 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
7/21/2021 Kala Pharmaceuticals KALA Maintain Buy
(N/A)
 
 
  Details
7/21/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
7/13/2021 Ambrx Biopharma AMAM New Coverage Buy
(N/A)
21.30
(28.00)
31.46% Details
7/13/2021 Cyteir Therapeutics CYT New Coverage Buy
(N/A)
19.65
(3.02)
-84.63% Details
6/29/2021 Ultragenyx Pharma RARE Upgrade Buy
(Neutral)
96.40
(44.22)
-54.13% Details
6/16/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
5/18/2021 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
4/19/2021 BioNTech BNTX Maintain Neutral
(N/A)
 
 
  Details
3/10/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
25.02
(17.13)
-31.53% Details
3/9/2021 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
2/12/2021 PTC Therapeutics PTCT Downgrade Neutral
(Buy)
63.27
(25.12)
-60.3% Details
2/12/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
2/12/2021 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
1/27/2021 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
1/13/2021 Ultragenyx Pharma RARE Maintain Neutral
(N/A)
 
 
  Details
12/18/2020 Amicus Therapeutics FOLD Maintain Buy
(N/A)
 
 
  Details
12/1/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/1/2020 BioNTech BNTX Downgrade Neutral
(Buy)
109.99
(86.00)
-21.81% Details
11/24/2020 SQZ Biotechnologies SQZ New Coverage Buy
(N/A)
27.62
(0.44)
-98.41% Details
11/20/2020 Prelude Therapeutics PRLD Downgrade Neutral
(Buy)
54.95
(4.02)
-92.68% Details
11/12/2020 Ultragenyx Pharma RARE Downgrade Neutral
(Buy)
117.48
(44.22)
-62.36% Details
11/10/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
10/27/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
10/20/2020 Prelude Therapeutics PRLD New Coverage Buy
(N/A)
32.69
(4.02)
-87.7% Details
10/15/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
10/15/2020 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
10/15/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
10/7/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
9/14/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
8/21/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/20/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
8/7/2020 Zogenix, Inc. ZGNX Maintain Buy
(N/A)
 
 
  Details
7/1/2020 Immunomedics IMMU Maintain Buy
(N/A)
 
 
  Details
6/24/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
6/11/2020 Kala Pharmaceuticals KALA Maintain Buy
(N/A)
 
 
  Details
6/10/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/27/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/27/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
5/12/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
5/8/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
4/8/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
4/7/2020 Incyte INCY Maintain Buy
(N/A)
 
 
  Details
2/26/2020 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
2/18/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
2/18/2020 Cortexyme Inc. CRTX Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 Kala Pharmaceuticals KALA Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 Galera Therapeutics GRTX Maintain Buy
(N/A)
 
 
  Details
2/18/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
2/18/2020 89bio Inc. ETNB Maintain Neutral
(N/A)
 
 
  Details
2/18/2020 MyoKardia MYOK Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Clovis Oncology CLVS Maintain Neutral
(N/A)
 
 
  Details
1/23/2020 Fulcrrum Therapeutics FULC Maintain Buy
(N/A)
 
 
  Details
1/23/2020 Principia Biopharma PRNB Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
1/14/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
1/14/2020 PTC Therapeutics PTCT Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
1/7/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/9/2019 89bio Inc. ETNB New Coverage Neutral
(N/A)
28.60
(9.15)
-68.01% Details
11/26/2019 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Alnylam Pharmaceuticals ALNY New Coverage Buy
(N/A)
90.85
(145.69)
60.36% Details
8/26/2019 The Medicines Company MDCO Maintain Buy
(N/A)
 
 
  Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
7/15/2019 Prevail Therapeutics PRVL New Coverage Buy
(N/A)
12.13
(23.00)
89.61% Details
6/21/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/13/2019 PTC Therapeutics PTCT Upgrade Buy
(Neutral)
40.53
(63.27)
56.11% Details
5/7/2019 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
12/20/2018 DBV Technologies S.A DBVT Downgrade Underperform
(Buy)
14.15
(0.66)
-95.34% Details
11/28/2018 GW Pharma GWPH Maintain Buy
(N/A)
 
 
  Details
11/12/2018 Tesaro TSRO Maintain Neutral
(N/A)
 
 
  Details
10/26/2018 Seattle Genetics SGEN Downgrade Underperform
(Neutral)
65.35
(117.08)
79.16% Details
10/9/2018 Principia Biopharma PRNB Upgrade Buy
(N/A)
26.37
(100.05)
279.41% Details
10/5/2018 Adamas Pharmaceuticals ADMS Downgrade Neutral
(Buy)
19.98
(6.67)
-66.62% Details
10/3/2018 PTC Therapeutics PTCT Upgrade Neutral
(Underperform)
45.28
(40.53)
-10.49% Details
9/28/2018 GW Pharma GWPH Maintain Buy
(Buy)
 
 
  Details
9/21/2018 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
9/14/2018 Zogenix, Inc. ZGNX New Coverage Buy
(N/A)
48.25
(26.68)
-44.7% Details
9/14/2018 Sarepta Therapeutics SRPT New Coverage Buy
(N/A)
150.77
(118.40)
-21.47% Details